Compare Microchip Technology Inc. (MCHP) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Microchip Technology Inc. vs ResMed Inc. — how do they compare? Microchip Technology Inc. trades at $78 (market cap $43.99B), while ResMed Inc. trades at $226.65 (market cap $32.78B). The key difference: Microchip Technology Inc. is the larger of the two by market cap, and Microchip Technology Inc. pays the higher dividend (2.25%). Which is the better fit depends on your goals.
| MCHP | RMD | |
|---|---|---|
Market Cap | $43.99B | $32.78B |
Sector | Technology | Health |
52-Week High | $102.97 | $293.73 |
52-Week Low | $49.02 | $182.82 |
Enterprise Value | $49.12B | $32.14B |
Dividend Yield | 2.25% | 1.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Microchip Technology (MCHP) trades at $77.69, down 4.11% on the day, with a neutral technical stance and strong analyst consensus. Recent earnings beats and robust data center growth, including a 98% revenue surge last quarter, highlight operational momentum. The stock's high P/E of 119.15 reflects growth expectations, while cash flow trends show variability, with 2025 net cash flow at $452 million.
Outlook is positive due to expanding AI and data center demand, supported by strategic acquisitions like Hailo. Risks include high valuation sensitivity and debt levels. Wall Street's average price target of $104.00 suggests 34% upside, with no sell ratings among 44 analysts.
ResMed (RMD) trades at $226.00, up 0.52% today, with a bullish technical signal from moving averages but a bearish oscillator reading. The company reported strong Q4 2026 earnings, beating EPS estimates with $2.95 versus $2.89 expected, and revenue growth of 9%. However, shares faced pressure due to weaker-than-expected fiscal 2027 revenue guidance. Fundamentals remain solid with a net income margin of 26.94% and robust cash flow from operations of $1.75 billion in 2025.
The outlook is mixed; strong profitability and consistent earnings beats support upside toward the $235.00 consensus price target, but near-term headwinds from guidance and cost pressures pose risks. Investment appeal hinges on execution against guidance and margin maintenance amid inflation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
